Published in Eur J Clin Invest on April 01, 1982
Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance. J Biol Chem (2007) 1.17
Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J Clin Invest (1988) 1.13
Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest (1990) 1.08
Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet (1999) 0.89
A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma. J Lipid Res (2008) 0.85
Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects. J Clin Invest (1984) 0.83
Variation at the apolipoprotein (apo) AI-CIII-AIV gene cluster and apo B gene loci is associated with lipoprotein and apolipoprotein levels in Italian children. Am J Hum Genet (1990) 0.80
LysoPC-acyl C16:0 is associated with brown adipose tissue activity in men. Metabolomics (2017) 0.75
Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet (1995) 21.03
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain. Br Med J (Clin Res Ed) (1988) 7.02
Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. Nucleic Acids Res (2001) 6.49
The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet (1977) 5.10
Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br Med J (Clin Res Ed) (1987) 5.01
Knowledge-based indexing of the medical literature: the Indexing Aid Project. J Am Soc Inf Sci (1987) 4.15
Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil (1993) 3.50
Appropriate responses to bioterrorist threats. BMJ (2001) 3.34
Structural relationships among Rhizobium meliloti symbiotic promoters. Cell (1983) 3.23
Learning of visceral and glandular responses. Science (1969) 3.13
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
MMR vaccination and autism 1998. BMJ (1998) 2.89
Interaction between transcription factors Sp1 and YY1. Nature (1993) 2.87
Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81
Cytogenetic analysis of a segment of the Y chromosome of Drosophila melanogaster. Genetics (1984) 2.75
The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region, Tanzania. AIDS (1992) 2.70
Myths in medicine. Immunisation. BMJ (1994) 2.52
Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A (2001) 2.44
Antenatal detection of HIV: national surveillance and unlinked anonymous survey. BMJ (2001) 2.41
Cimetidine and HDL cholesterol. Lancet (1983) 2.40
The British Paediatric Surveillance Unit--a pioneering method for investigating the less common disorders of childhood. Report of a seminar held in June 1995. Child Care Health Dev (1998) 2.32
Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr (1996) 2.26
Synaptic transmission between individual pyramidal neurons of the rat visual cortex in vitro. J Neurosci (1991) 2.26
Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County. Am J Prev Med (1998) 2.23
Lipoprotein fractionation by a precipitation method. A simple quantitative procedure. Clin Chim Acta (1976) 2.19
Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J (2001) 2.16
Cardiac surgery in Wessex: review of 1000 consecutive open-heart procedures. Br Med J (1976) 2.16
Contraindications to whooping-cough immunisation--myths or realities? Lancet (1985) 2.13
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res (2000) 2.05
Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. Am J Med (1994) 1.96
An operant approach to rehabilitation medicine: overcoming learned nonuse by shaping. J Exp Anal Behav (1994) 1.96
Bacterial vaginosis: a public health review. BJOG (2001) 1.95
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Letter: High-density lipoprotein and atherosclerosis. Lancet (1975) 1.93
Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill (2010) 1.90
Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest (1966) 1.88
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J (1987) 1.88
Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J (1992) 1.88
Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86
Resurgence of syphilis in England: time for more radical and nationally coordinated approaches. Sex Transm Infect (2001) 1.85
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Regulation of macrophage activation. Cell Mol Life Sci (2003) 1.83
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest (1975) 1.82
Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) (1981) 1.80
Intralenticular hemorrhage following blunt ocular trauma. Arch Ophthalmol (1998) 1.78
Epidemiology of genital Chlamydia trachomatis in England and Wales. Genitourin Med (1997) 1.78
Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill (2014) 1.78
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill (2013) 1.77
The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology. Circulation (1996) 1.76
Epidemic perinatal listeriosis. Pediatr Infect Dis (1984) 1.74
A training procedure for immunization. Health Trends (1987) 1.67
National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill (2008) 1.63
Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet (1981) 1.61
Randomised trial of one versus two doses of prostaglandin E2 for induction of labour: 2. Analysis of cost. Br J Obstet Gynaecol (1997) 1.59
Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts. J Clin Invest (1977) 1.58
Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses. Euro Surveill (2009) 1.58
Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest (1980) 1.55
Metabolism of amylobarbitone in patients with chronic liver disease. Br J Pharmacol (1972) 1.50
Serum bile acids in liver disease. Gut (1971) 1.50
Responding to new severe diseases--the case for routine hospital surveillance and clinical networks in Europe. Euro Surveill (2010) 1.49
Distribution and characterization of canine Chagas disease in Texas. Vet Parasitol (2008) 1.48
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res (1975) 1.47
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther (2007) 1.45
Managing major public health crises. BMJ (2001) 1.45
A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 2. Risk factors and health seeking behaviour. Genitourin Med (1993) 1.42
Distribution of vaccine/antivirals and the 'least spread line' in a stratified population. J R Soc Interface (2009) 1.42
Is povidone-iodine a hemostyptic? A clinical study. Int J Oral Maxillofac Surg (2006) 1.42
The structure of d(CGCGAAT[]TCGCG) . d(CGCGAATTCGCG); the incorporation of a thymine photodimer into a B-DNA helix. Nucleic Acids Res (1984) 1.41
Interactions between learned and physical factors in mental illness. Semin Psychiatry (1972) 1.40
Contra-indications to measles and whooping cough vaccination: reality and mythology. Practitioner (1986) 1.40
Infant feeding policy and practice in the presence of HIV-1 infection. AIDS (1995) 1.39
A population-based study of syphilis and sexually transmitted disease syndromes in north-western Tanzania. 1. Prevalence and incidence. Genitourin Med (1993) 1.39
Antenatal screening for HIV in the UK: what is to be done? J Med Screen (1998) 1.39
HIV and tuberculosis in the commonwealth. BMJ (1999) 1.39
Science, sense, and nonsense about HIV in Africa. Commun Dis Public Health (2000) 1.39
Nonsteroidal antiinflammatory agents. I. 6-substituted 2-naphthylacetic acids. J Med Chem (1970) 1.38
The value of behavioral research on animals. Am Psychol (1985) 1.38
The child health clinic: results of a new strategy of community care in a deprived area. Lancet (1986) 1.38
Psychiatric training for family doctors: what do GP registrars want and can a brief course provide this? Med Educ (1999) 1.37
Differences in body composition of black and white girls. Am J Clin Nutr (1996) 1.36
Evaluation of syndromic surveillance based on National Health Service Direct derived data--England and Wales. MMWR Morb Mortal Wkly Rep (2005) 1.36
Variant Creutzfeldt-Jakob disease in UK children: a national surveillance study. Lancet (2000) 1.34
Free energy perturbation calculations on binding and catalysis after mutating Asn 155 in subtilisin. Nature (1987) 1.33
Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J (1987) 1.33
Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation (2001) 1.32
Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia. Eur J Clin Invest (1980) 1.32
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency. Am J Hum Genet (1990) 1.31
Serum-bile-acids in the stagnant-loop syndrome. Lancet (1969) 1.30
Rare disease surveillance: An international perspective. Paediatr Child Health (2001) 1.30